Oxford Biomedica plc (OXBDF)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Frank Mathias
|
CEO & Director | 2.06M | -- | 1962 |
|
Dr. Lucinda Clair Crabtree Ph.D.
|
CFO & Director | 1.33M | -- | 1979 |
|
Mr. Eric Schmidhäuser
|
Chief Operating Officer | -- | -- | -- |
|
Ms. Sophia Bolhassan
|
Head of Investor Relations | -- | -- | -- |
|
Ms. Natalie Louise Walter
|
Chief Legal Officer & Company Secretary | -- | -- | 1973 |
|
Ms. Lisa Doman
|
Chief People Officer | -- | -- | -- |
|
Dr. Kyriacos Mitrophanous Ph.D.
|
Chief Innovation Officer | -- | -- | -- |
|
Ms. Kati Hudson
|
Head of Intellectual Property & Contracts | -- | -- | -- |
|
Mr. David M. Backer M.B.A.
|
Durham Site Head | -- | -- | -- |
|
Dr. Sebastien Ribault
|
Chief Business Officer | -- | -- | -- |
Oxford Biomedica plc
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 1,017
Description
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems; InAAVate, a proprietary ‘plug and play' dual-plasmid system for transient transfection, as well as a standard triple transfection system for AAV-based gene therapies. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.
Corporate Governance
Upcoming Events
September 22, 2026 at 8:00 PM UTC
Oxford Biomedica plc Earnings Date
Recent Events
Recent Events Information Not Available
